[HTML][HTML] Adipose tissue-derived mesenchymal stromal/stem cells, obesity and the tumor microenvironment of breast cancer

A Ritter, NN Kreis, SC Hoock, C Solbach, F Louwen… - Cancers, 2022 - mdpi.com
Simple Summary Adipose tissue is the major microenvironment of breast cancer. Adipose
tissue-derived mesenchymal stromal/stem cells (ASCs/MSCs) are key players in adipose …

[HTML][HTML] Circulating tumour cells: The Good, the Bad and the Ugly

M Bates, BM Mohamed, MP Ward, TE Kelly… - … et Biophysica Acta (BBA …, 2023 - Elsevier
This review is an overview of the current knowledge regarding circulating tumour cells
(CTCs), which are potentially the most lethal type of cancer cell, and may be a key …

[HTML][HTML] Cancer-educated mammary adipose tissue-derived stromal/stem cells in obesity and breast cancer: spatial regulation and function

A Ritter, NN Kreis, S Roth, A Friemel, BK Safdar… - Journal of Experimental …, 2023 - Springer
Background Breast cancer is the most frequently diagnosed cancer and a common cause of
cancer-related death in women. It is well recognized that obesity is associated with an …

Necroptosis‐Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor‐Infiltrating Lymphocytes in Breast Cancer

S Tao, K Tao, X Cai - Journal of Oncology, 2022 - Wiley Online Library
Necroptosis plays an important role in tumor genesis and progression. This study aims to
identify necroptosis‐related lncRNAs (NR‐lncRNAs) in breast cancer (BC), and their …

[HTML][HTML] Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients

E Muraro, F Del Ben, M Turetta, D Cesselli… - Frontiers in …, 2022 - frontiersin.org
Background Metastatic breast cancer (mBC) is a heterogeneous disease with varying
responses to treatments and clinical outcomes, still requiring the identification of reliable …

[HTML][HTML] Regression and eradication of triple-negative breast carcinoma in 4T1 mouse model by combination immunotherapies

S Nahar, Y Huang, BA Nagy, JA Zebala, DY Maeda… - Cancers, 2023 - mdpi.com
Simple Summary There is currently no effective therapy available for triple-negative breast
cancer. To look for potentially effective treatment, we used the 4T1 mouse model of triple …

YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR

C Zhang, S Chen, W Wang, Y Gao - Functional & Integrative Genomics, 2023 - Springer
It is well-established that breast cancer is a highly prevalent malignancy among women,
emphasizing the need to investigate mechanisms underlying its pathogenesis and …

[HTML][HTML] Multifunctional plant virus nanoparticles for targeting breast cancer tumors

M Shahgolzari, H Dianat-Moghadam, A Yavari… - Vaccines, 2022 - mdpi.com
Breast cancer treatment using plant-virus-based nanoparticles (PVNPs) has achieved
considerable success in preclinical studies. PVNP-based breast cancer therapies include …

[HTML][HTML] CXC ELR-positive chemokines as diagnostic and prognostic markers for breast cancer patients

J Motyka, A Kicman, M Kulesza, S Ławicki - Cancers, 2023 - mdpi.com
Simple Summary Currently, breast cancer diagnostics do not have readily available
diagnostic and prognostic tools, especially in the early stages of the disease. Therefore …

Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment

JH Lee, JH An, HY Youn - Veterinary and Comparative …, 2023 - Wiley Online Library
Recent studies have shown that tumour cells express tumour necrosis factor‐inducible gene
6 (TSG‐6) and its protein, which is known to play a key role in regulating excessive immune …